Spotlight: Jun 29, 2024
By designing new tools that can analyze huge libraries of immune cells and their targets, Michael Birnbaum hopes to generate better T cell therapies for cancer and other diseases. “T-cells are so diverse in terms of what they recognize and what they do,” he says.